首页> 美国卫生研究院文献>Pharmaceutics >In Vitro Evaluation of Self-Nano-Emulsifying Drug Delivery Systems (SNEDDS) Containing Room Temperature Ionic Liquids (RTILs) for the Oral Delivery of Amphotericin B
【2h】

In Vitro Evaluation of Self-Nano-Emulsifying Drug Delivery Systems (SNEDDS) Containing Room Temperature Ionic Liquids (RTILs) for the Oral Delivery of Amphotericin B

机译:对含有室温离子液体(RTIL)的自纳米乳化药物递送系统(RTILS)的体外评估用于口服递送两性霉素B.

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Amphotericin B (AmpB), one of the most commonly used agents in the treatment of severe fungal infections and life-threatening parasitic diseases such as visceral Leishmaniasis, has a negligible oral bioavailability, primarily due to a low solubility and permeability. To develop an oral formulation, medium chain triglycerides and nonionic surfactants in a self-nano-emulsifying drug delivery system (SNEDDS) containing AmpB were combined with room temperature ionic liquids (RTILs) of imidazolium. The presence of ionic liquids significantly enhanced the solubility of AmpB, exhibited a low toxicity and increased the transport of AmpB across Caco-2 cell monolayers. The combination of RTILs with a lipid formulation might be a promising strategy to improve the oral bioavailability of AmpB.
机译:两性霉素B(AMPB)是治疗严重真菌感染和危及危及李立法中的生命危及的寄生虫疾病之一的一种,具有可忽略不计的口腔生物利用度,主要是由于溶解度低和渗透性。为了在含有AMPB的自纳米乳化药物输送系统(SNEDDS)中制定口服制剂,中链甘油三酯和非离子表面活性剂与咪唑鎓的室温离子液体(RTIL)组合。离子液体的存在显着增强了AMPB的溶解度,表现出低毒性并增加了Caco-2细胞单层的AMPB的运输。 RTILS与脂质制剂的组合可能是提高AMPB口服生物利用度的有希望的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号